These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30625081)

  • 1. [Not Available].
    Ushkalova EA; Zyryanov SK; Zatolochina KE
    Kardiologiia; 2018 Nov; 58(11):82-93. PubMed ID: 30625081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension.
    Lian TY; Jiang X; Jing ZC
    Drug Des Devel Ther; 2017; 11():1195-1207. PubMed ID: 28458514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Bishop BM
    Am J Health Syst Pharm; 2014 Nov; 71(21):1839-44. PubMed ID: 25320133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Riociguat: a review of its use in patients with chronic thromboembolic pulmonary hypertension or pulmonary arterial hypertension.
    Garnock-Jones KP
    Drugs; 2014 Nov; 74(17):2065-78. PubMed ID: 25352393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riociguat for the treatment of pulmonary hypertension.
    Meis T; Behr J
    Expert Opin Pharmacother; 2014 Nov; 15(16):2419-27. PubMed ID: 25260791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat].
    Gratsianskaya SE; Valieva ZS; Martynyuk TV
    Ter Arkh; 2020 Oct; 92(9):77-84. PubMed ID: 33346435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical Therapy in Chronic Thromboembolic Pulmonary Hypertension.
    Pepke-Zaba J; Jais X; Channick R
    Ann Am Thorac Soc; 2016 Jul; 13 Suppl 3():S248-54. PubMed ID: 27571006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.
    Kim NH; D'Armini AM; Grimminger F; Grünig E; Hoeper MM; Jansa P; Mayer E; Neurohr C; Simonneau G; Torbicki A; Wang C; Fritsch A; Davie N; Ghofrani HA
    Heart; 2017 Apr; 103(8):599-606. PubMed ID: 28011757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The soluble guanylate cyclase stimulator riociguat is the first-line therapy for chronic thromboembolic pulmonary hypertension patients].
    Valieva ZS; Gratsianskaya SE; Martynyuk TV
    Kardiologiia; 2020 Sep; 60(8):115-123. PubMed ID: 33155967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.
    Ghofrani HA; Gomez Sanchez MA; Humbert M; Pittrow D; Simonneau G; Gall H; Grünig E; Klose H; Halank M; Langleben D; Snijder RJ; Escribano Subias P; Mielniczuk LM; Lange TJ; Vachiéry JL; Wirtz H; Helmersen DS; Tsangaris I; Barberá JA; Pepke-Zaba J; Boonstra A; Rosenkranz S; Ulrich S; Steringer-Mascherbauer R; Delcroix M; Jansa P; Šimková I; Giannakoulas G; Klotsche J; Williams E; Meier C; Hoeper MM;
    Respir Med; 2021 Mar; 178():106220. PubMed ID: 33540340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension.
    Hoeper MM
    Eur Respir Rev; 2015 Jun; 24(136):272-82. PubMed ID: 26028639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and effectiveness of riociguat to treat chronic thromboembolic pulmonary hypertension.
    DeSouza SA; Preston IR
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):467-76. PubMed ID: 25797801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble Guanylate Cyclase Stimulators and Activators: Novel Therapies for Pulmonary Vascular Disease or a Different Method of Increasing cGMP?
    Koress C; Swan K; Kadowitz P
    Curr Hypertens Rep; 2016 Apr; 18(5):42. PubMed ID: 27118316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Riociguat: stimulator of soluble guanylate-cyclase. New mode of action for the treatment of pulmonary arterial and non operable chronic thromboembolic pulmonary hypertension].
    Leuchte HH; Behr J; Ewert R; Ghofrani HA; Grünig E; Halank M; Held M; Klose H; Rosenkranz S; Schermuly RT; Wilkens H; Hoeper MM
    Pneumologie; 2015 Mar; 69(3):135-43. PubMed ID: 25750094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Chronic Thromboembolic Pulmonary Hypertension: The Role of Medical Therapy and Balloon Pulmonary Angioplasty.
    Fernandes TM; Poch DS; Auger WR
    Methodist Debakey Cardiovasc J; 2016; 12(4):205-212. PubMed ID: 28289495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Riociguat: an upcoming therapy in chronic thromboembolic pulmonary hypertension?
    Kim NH
    Eur Respir Rev; 2010 Mar; 19(115):68-71. PubMed ID: 20956169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developments in pulmonary arterial hypertension-targeted therapy for chronic thromboembolic pulmonary hypertension.
    Hadinnapola C; Pepke-Zaba J
    Expert Rev Respir Med; 2015 Oct; 9(5):559-69. PubMed ID: 26366805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Benza RL; Langleben D; Hemnes AR; Vonk Noordegraaf A; Rosenkranz S; Thenappan T; Hassoun PM; Preston IR; Ghio S; Badagliacca R; Vizza CD; Lang IM; Meier C; Grünig E
    Eur Respir Rev; 2022 Dec; 31(166):. PubMed ID: 36198418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial.
    Simonneau G; D'Armini AM; Ghofrani HA; Grimminger F; Jansa P; Kim NH; Mayer E; Pulido T; Wang C; Colorado P; Fritsch A; Meier C; Nikkho S; Hoeper MM
    Lancet Respir Med; 2016 May; 4(5):372-80. PubMed ID: 27067478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riociguat: first global approval.
    Conole D; Scott LJ
    Drugs; 2013 Nov; 73(17):1967-75. PubMed ID: 24218053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.